Effect of tanshinone II A on proliferation and apoptosis of human lung cancer cell line A549/CDDP

Journal of Practical Oncology

Volumn 25, Issue 6, 2010, Pages

  Wang, Jiang Feng ^a   Zhou, Xie Lai ^a   Yuan, Hong ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis drug effects; Carcinoma; Cell proliferation; Cultured; Drug resistance; Genes; Lung neoplasms pathology; Neoplasm drug effects; Non small cell lung pathology; Tanshinone pharmacology; Tunor cells

Indexed keywords

PROTEIN BAX; SURVIVIN; TANSHINONE IIA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN EXPRESSION;

EID: 78651284819     PISSN: 10011692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Waxman DJ, Schwartz PS. Harnessing apoptosis for improved anticancer gene therapy [J]. Cancer Res, 2003, 63(24): 8563-8572.
2. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin [J]. Nature, 1998, 396(6711): 580-584.
3. Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspas3/p21. complex formation as a result of interaction with CDK4 to resist Fas- mediated cell death [J]. Oncogene, 2000, 19(10): 1346-1353. (Pubitemid 30160627)